nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—Appendicitis—Octreotide—thymus cancer	0.0568	0.0609	CcSEcCtD
Sitaxentan—Gallbladder disorder—Octreotide—thymus cancer	0.0535	0.0574	CcSEcCtD
Sitaxentan—Basal cell carcinoma—Octreotide—thymus cancer	0.0373	0.04	CcSEcCtD
Sitaxentan—Abdominal tenderness—Octreotide—thymus cancer	0.0348	0.0373	CcSEcCtD
Sitaxentan—Pruritus generalised—Octreotide—thymus cancer	0.0263	0.0282	CcSEcCtD
Sitaxentan—Goitre—Octreotide—thymus cancer	0.0246	0.0264	CcSEcCtD
Sitaxentan—VIIth nerve paralysis—Octreotide—thymus cancer	0.0214	0.023	CcSEcCtD
Sitaxentan—Pancreatitis acute—Octreotide—thymus cancer	0.019	0.0204	CcSEcCtD
Sitaxentan—Proctalgia—Octreotide—thymus cancer	0.0187	0.0201	CcSEcCtD
Sitaxentan—Sinus bradycardia—Octreotide—thymus cancer	0.0179	0.0192	CcSEcCtD
Sitaxentan—Anorectal discomfort—Octreotide—thymus cancer	0.0161	0.0172	CcSEcCtD
Sitaxentan—Pregnancy—Octreotide—thymus cancer	0.0155	0.0166	CcSEcCtD
Sitaxentan—Haemorrhoids—Octreotide—thymus cancer	0.0149	0.016	CcSEcCtD
Sitaxentan—Cholelithiasis—Octreotide—thymus cancer	0.0141	0.0152	CcSEcCtD
Sitaxentan—Haematoma—Octreotide—thymus cancer	0.014	0.015	CcSEcCtD
Sitaxentan—Peptic ulcer—Octreotide—thymus cancer	0.0131	0.0141	CcSEcCtD
Sitaxentan—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0128	0.0137	CcSEcCtD
Sitaxentan—Metrorrhagia—Octreotide—thymus cancer	0.0123	0.0132	CcSEcCtD
Sitaxentan—Herpes zoster—Octreotide—thymus cancer	0.0117	0.0125	CcSEcCtD
Sitaxentan—Cholestasis—Octreotide—thymus cancer	0.0116	0.0124	CcSEcCtD
Sitaxentan—Otitis media—Octreotide—thymus cancer	0.0113	0.0121	CcSEcCtD
Sitaxentan—Petechiae—Octreotide—thymus cancer	0.0107	0.0115	CcSEcCtD
Sitaxentan—Endocrine disorder—Octreotide—thymus cancer	0.0106	0.0114	CcSEcCtD
Sitaxentan—Contusion—Octreotide—thymus cancer	0.0101	0.0108	CcSEcCtD
Sitaxentan—Breast pain—Octreotide—thymus cancer	0.0101	0.0108	CcSEcCtD
Sitaxentan—Amenorrhoea—Octreotide—thymus cancer	0.01	0.0107	CcSEcCtD
Sitaxentan—Viral infection—Octreotide—thymus cancer	0.00972	0.0104	CcSEcCtD
Sitaxentan—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00966	0.0104	CcSEcCtD
Sitaxentan—Cellulitis—Octreotide—thymus cancer	0.00966	0.0104	CcSEcCtD
Sitaxentan—Herpes simplex—Octreotide—thymus cancer	0.00953	0.0102	CcSEcCtD
Sitaxentan—Muscle twitching—Octreotide—thymus cancer	0.00894	0.0096	CcSEcCtD
Sitaxentan—Hyperkalaemia—Octreotide—thymus cancer	0.00863	0.00926	CcSEcCtD
Sitaxentan—Eructation—Octreotide—thymus cancer	0.00863	0.00926	CcSEcCtD
Sitaxentan—Wheezing—Octreotide—thymus cancer	0.00853	0.00915	CcSEcCtD
Sitaxentan—Candida infection—Octreotide—thymus cancer	0.00839	0.009	CcSEcCtD
Sitaxentan—Vaginal infection—Octreotide—thymus cancer	0.00829	0.0089	CcSEcCtD
Sitaxentan—EDNRB—cardiac atrium—thymus cancer	0.00791	0.116	CbGeAlD
Sitaxentan—EDNRB—pituitary gland—thymus cancer	0.00773	0.114	CbGeAlD
Sitaxentan—Sleep disorder—Octreotide—thymus cancer	0.00737	0.0079	CcSEcCtD
Sitaxentan—Gastroenteritis—Octreotide—thymus cancer	0.00719	0.00772	CcSEcCtD
Sitaxentan—Deafness—Octreotide—thymus cancer	0.00713	0.00765	CcSEcCtD
Sitaxentan—Cardiac failure congestive—Octreotide—thymus cancer	0.00703	0.00754	CcSEcCtD
Sitaxentan—Nasal congestion—Octreotide—thymus cancer	0.007	0.00751	CcSEcCtD
Sitaxentan—Menopausal symptoms—Octreotide—thymus cancer	0.00676	0.00725	CcSEcCtD
Sitaxentan—Visual disturbance—Octreotide—thymus cancer	0.00673	0.00722	CcSEcCtD
Sitaxentan—EDNRB—thyroid gland—thymus cancer	0.00666	0.0979	CbGeAlD
Sitaxentan—Arthritis—Octreotide—thymus cancer	0.00656	0.00704	CcSEcCtD
Sitaxentan—EDNRA—cardiac atrium—thymus cancer	0.00654	0.0961	CbGeAlD
Sitaxentan—Hypoglycaemia—Octreotide—thymus cancer	0.00653	0.00701	CcSEcCtD
Sitaxentan—EDNRA—pituitary gland—thymus cancer	0.00639	0.0939	CbGeAlD
Sitaxentan—Osteoarthritis—Octreotide—thymus cancer	0.00638	0.00684	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00638	0.00684	CcSEcCtD
Sitaxentan—EDNRB—lung—thymus cancer	0.00605	0.0889	CbGeAlD
Sitaxentan—Dehydration—Octreotide—thymus cancer	0.00593	0.00636	CcSEcCtD
Sitaxentan—Dry skin—Octreotide—thymus cancer	0.00584	0.00627	CcSEcCtD
Sitaxentan—Abdominal pain upper—Octreotide—thymus cancer	0.00582	0.00625	CcSEcCtD
Sitaxentan—Cramp muscle—Octreotide—thymus cancer	0.00574	0.00616	CcSEcCtD
Sitaxentan—Muscular weakness—Octreotide—thymus cancer	0.00562	0.00603	CcSEcCtD
Sitaxentan—Asthma—Octreotide—thymus cancer	0.00551	0.00591	CcSEcCtD
Sitaxentan—EDNRA—thyroid gland—thymus cancer	0.00551	0.0809	CbGeAlD
Sitaxentan—Bronchitis—Octreotide—thymus cancer	0.0053	0.00569	CcSEcCtD
Sitaxentan—Abdominal discomfort—Octreotide—thymus cancer	0.00528	0.00567	CcSEcCtD
Sitaxentan—Dysuria—Octreotide—thymus cancer	0.00515	0.00553	CcSEcCtD
Sitaxentan—Pollakiuria—Octreotide—thymus cancer	0.00509	0.00546	CcSEcCtD
Sitaxentan—EDNRA—lung—thymus cancer	0.005	0.0735	CbGeAlD
Sitaxentan—Weight decreased—Octreotide—thymus cancer	0.00499	0.00535	CcSEcCtD
Sitaxentan—Hyperglycaemia—Octreotide—thymus cancer	0.00497	0.00533	CcSEcCtD
Sitaxentan—Jaundice—Octreotide—thymus cancer	0.00479	0.00514	CcSEcCtD
Sitaxentan—Conjunctivitis—Octreotide—thymus cancer	0.00478	0.00512	CcSEcCtD
Sitaxentan—Haematuria—Octreotide—thymus cancer	0.00469	0.00503	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Octreotide—thymus cancer	0.00465	0.00499	CcSEcCtD
Sitaxentan—Epistaxis—Octreotide—thymus cancer	0.00463	0.00497	CcSEcCtD
Sitaxentan—Sinusitis—Octreotide—thymus cancer	0.00461	0.00495	CcSEcCtD
Sitaxentan—Bradycardia—Octreotide—thymus cancer	0.00449	0.00482	CcSEcCtD
Sitaxentan—Rhinitis—Octreotide—thymus cancer	0.00442	0.00475	CcSEcCtD
Sitaxentan—Hepatitis—Octreotide—thymus cancer	0.00441	0.00473	CcSEcCtD
Sitaxentan—Oedema peripheral—Octreotide—thymus cancer	0.00435	0.00466	CcSEcCtD
Sitaxentan—Visual impairment—Octreotide—thymus cancer	0.00425	0.00456	CcSEcCtD
Sitaxentan—EDNRB—lymph node—thymus cancer	0.00414	0.0608	CbGeAlD
Sitaxentan—Tinnitus—Octreotide—thymus cancer	0.00411	0.00441	CcSEcCtD
Sitaxentan—Flushing—Octreotide—thymus cancer	0.00409	0.00439	CcSEcCtD
Sitaxentan—Cardiac disorder—Octreotide—thymus cancer	0.00409	0.00439	CcSEcCtD
Sitaxentan—Immune system disorder—Octreotide—thymus cancer	0.00398	0.00428	CcSEcCtD
Sitaxentan—Alopecia—Octreotide—thymus cancer	0.0039	0.00418	CcSEcCtD
Sitaxentan—Mental disorder—Octreotide—thymus cancer	0.00386	0.00415	CcSEcCtD
Sitaxentan—Malnutrition—Octreotide—thymus cancer	0.00384	0.00412	CcSEcCtD
Sitaxentan—Tension—Octreotide—thymus cancer	0.00377	0.00404	CcSEcCtD
Sitaxentan—Nervousness—Octreotide—thymus cancer	0.00373	0.004	CcSEcCtD
Sitaxentan—Muscle spasms—Octreotide—thymus cancer	0.00369	0.00396	CcSEcCtD
Sitaxentan—CYP2C19—hematopoietic system—thymus cancer	0.00368	0.054	CbGeAlD
Sitaxentan—Tremor—Octreotide—thymus cancer	0.0036	0.00386	CcSEcCtD
Sitaxentan—Ill-defined disorder—Octreotide—thymus cancer	0.00356	0.00382	CcSEcCtD
Sitaxentan—Anaemia—Octreotide—thymus cancer	0.00355	0.00381	CcSEcCtD
Sitaxentan—Agitation—Octreotide—thymus cancer	0.00353	0.00379	CcSEcCtD
Sitaxentan—Malaise—Octreotide—thymus cancer	0.00346	0.00372	CcSEcCtD
Sitaxentan—Vertigo—Octreotide—thymus cancer	0.00345	0.0037	CcSEcCtD
Sitaxentan—EDNRA—lymph node—thymus cancer	0.00342	0.0503	CbGeAlD
Sitaxentan—Chest pain—Octreotide—thymus cancer	0.00327	0.00351	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00325	0.00348	CcSEcCtD
Sitaxentan—Discomfort—Octreotide—thymus cancer	0.00323	0.00347	CcSEcCtD
Sitaxentan—Dry mouth—Octreotide—thymus cancer	0.0032	0.00343	CcSEcCtD
Sitaxentan—Oedema—Octreotide—thymus cancer	0.00313	0.00336	CcSEcCtD
Sitaxentan—Infection—Octreotide—thymus cancer	0.00311	0.00334	CcSEcCtD
Sitaxentan—Nervous system disorder—Octreotide—thymus cancer	0.00307	0.0033	CcSEcCtD
Sitaxentan—Thrombocytopenia—Octreotide—thymus cancer	0.00307	0.00329	CcSEcCtD
Sitaxentan—Tachycardia—Octreotide—thymus cancer	0.00306	0.00328	CcSEcCtD
Sitaxentan—Skin disorder—Octreotide—thymus cancer	0.00304	0.00327	CcSEcCtD
Sitaxentan—Anorexia—Octreotide—thymus cancer	0.00299	0.00321	CcSEcCtD
Sitaxentan—CYP2C9—hematopoietic system—thymus cancer	0.00285	0.0419	CbGeAlD
Sitaxentan—Insomnia—Octreotide—thymus cancer	0.00283	0.00304	CcSEcCtD
Sitaxentan—Somnolence—Octreotide—thymus cancer	0.00279	0.00299	CcSEcCtD
Sitaxentan—Dyspepsia—Octreotide—thymus cancer	0.00276	0.00296	CcSEcCtD
Sitaxentan—Decreased appetite—Octreotide—thymus cancer	0.00272	0.00292	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Octreotide—thymus cancer	0.00271	0.0029	CcSEcCtD
Sitaxentan—Fatigue—Octreotide—thymus cancer	0.0027	0.0029	CcSEcCtD
Sitaxentan—Pain—Octreotide—thymus cancer	0.00268	0.00288	CcSEcCtD
Sitaxentan—Constipation—Octreotide—thymus cancer	0.00268	0.00288	CcSEcCtD
Sitaxentan—Feeling abnormal—Octreotide—thymus cancer	0.00258	0.00277	CcSEcCtD
Sitaxentan—Urticaria—Octreotide—thymus cancer	0.00249	0.00267	CcSEcCtD
Sitaxentan—Body temperature increased—Octreotide—thymus cancer	0.00248	0.00266	CcSEcCtD
Sitaxentan—Hypersensitivity—Octreotide—thymus cancer	0.00231	0.00248	CcSEcCtD
Sitaxentan—Asthenia—Octreotide—thymus cancer	0.00225	0.00241	CcSEcCtD
Sitaxentan—CYP3A4—hematopoietic system—thymus cancer	0.00217	0.0319	CbGeAlD
Sitaxentan—Diarrhoea—Octreotide—thymus cancer	0.00214	0.0023	CcSEcCtD
Sitaxentan—Dizziness—Octreotide—thymus cancer	0.00207	0.00222	CcSEcCtD
Sitaxentan—Vomiting—Octreotide—thymus cancer	0.00199	0.00214	CcSEcCtD
Sitaxentan—Rash—Octreotide—thymus cancer	0.00198	0.00212	CcSEcCtD
Sitaxentan—Dermatitis—Octreotide—thymus cancer	0.00197	0.00212	CcSEcCtD
Sitaxentan—Headache—Octreotide—thymus cancer	0.00196	0.00211	CcSEcCtD
Sitaxentan—Nausea—Octreotide—thymus cancer	0.00186	0.002	CcSEcCtD
